Literature DB >> 26564387

Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation?

Panagis Drakatos1, Guy Leschziner1,2.   

Abstract

Patients with narcolepsy usually develop excessive daytime sleepiness (EDS) before or coincide with the occurrence of cataplexy, with the latter most commonly associated with low cerebrospinal fluid (CSF) hypocretin-1 levels. Cataplexy preceding the development of other features of narcolepsy is a rare phenomenon. We describe a case of isolated cataplexy in the context of two non-diagnostic multiple sleep latency tests and normal CSF-hypocretin-1 levels (217 pg/mL) who gradually developed EDS and low CSF-hypocretin-1 (< 110 pg/mL).
© 2016 American Academy of Sleep Medicine.

Entities:  

Keywords:  cataplexy; hypocretin; narcolepsy; orexin

Mesh:

Substances:

Year:  2016        PMID: 26564387      PMCID: PMC4773628          DOI: 10.5664/jcsm.5604

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  5 in total

1.  Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness.

Authors:  M A Carskadon; W C Dement; M M Mitler; T Roth; P R Westbrook; S Keenan
Journal:  Sleep       Date:  1986-12       Impact factor: 5.849

2.  The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Authors:  Emmanuel Mignot; Gert Jan Lammers; Beth Ripley; Michele Okun; Sonia Nevsimalova; Sebastiaan Overeem; Jitka Vankova; Jed Black; John Harsh; Claudio Bassetti; Harald Schrader; Seiji Nishino
Journal:  Arch Neurol       Date:  2002-10

3.  HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.

Authors:  E Mignot; R Hayduk; J Black; F C Grumet; C Guilleminault
Journal:  Sleep       Date:  1997-11       Impact factor: 5.849

4.  The clinical spectrum of narcolepsy with cataplexy: a reappraisal.

Authors:  Christian Sturzenegger; Claudio L Bassetti
Journal:  J Sleep Res       Date:  2004-12       Impact factor: 3.981

5.  Relationship between CSF hypocretin levels and hypocretin neuronal loss.

Authors:  Dmitry Gerashchenko; Eric Murillo-Rodriguez; Ling Lin; Man Xu; Laura Hallett; Seiji Nishino; Emmanuel Mignot; Priyattam J Shiromani
Journal:  Exp Neurol       Date:  2003-12       Impact factor: 5.330

  5 in total
  2 in total

1.  Narcolepsy with resolution of cataplexy and persisting orexin deficiency.

Authors:  Danielle Wasserman; Claudio L A Bassetti; Ivana Rosenzweig
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

2.  Mechanistic insights into influenza vaccine-associated narcolepsy.

Authors:  S Sohail Ahmed; Lawrence Steinman
Journal:  Hum Vaccin Immunother       Date:  2016-03-31       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.